The effect of treatment modality on health-related quality of life in elderly patients with prostate cancer: A prospective observational study

Not Applicable

• Conditions: Prostate cancer

• Registration Number: JPRN-UMIN000040802
• Lead Sponsor: Dept. of Urology, Hirosaki University Graduate School of Medicine

Brief Summary

The oncologic outcomes and PROs in select patients with prostate cancer aged>=75 years were feasible and acceptable with RARP.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-01
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 752

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with locally advanced (T4 or N+) or metastatic prostate cancer treated with radical prostatectomy or radiation therapy, 2) not treated with radical prostatectomy or radiation therapy,and 3)without HRQOL evaluation (EPIC and SF-8) at baseline, 3 and 12 months after treatment.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HRQOL comparison: radical prostatectomy vs. radiation therapy in elderly patients (>=75 yrs)

Secondary Outcome Measures

Name	Time	Method
HRQOL comparison: radical prostatectomy vs. radiation therapy in elderly patients (<75 yrs) Frailty comparison:radical prostatectomy vs. radiation therapy in elderly patients (>=75 yrs)